PAA
Peregrine Asset Advisers’s iShares Biotechnology ETF IBB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $369K | Hold |
2,916
| – | – | 0.12% | 118 |
|
|
2025
Q1 | $373K | Sell |
2,916
-5
| -0.2% | -$639 | 0.14% | 113 |
|
|
2024
Q4 | $386K | Sell |
2,921
-546
| -16% | -$72.2K | 0.14% | 107 |
|
|
2024
Q3 | $505K | Buy |
3,467
+222
| +7% | +$32.3K | 0.17% | 103 |
|
|
2024
Q2 | $445K | Hold |
3,245
| – | – | 0.18% | 99 |
|
|
2024
Q1 | $445K | Hold |
3,245
| – | – | 0.18% | 98 |
|
|
2023
Q4 | $441K | Hold |
3,245
| – | – | 0.21% | 90 |
|
|
2023
Q3 | $397K | Buy |
+3,245
| New | +$397K | 0.21% | 90 |
|
|
2021
Q1 | – | Sell |
-24,774
| Closed | -$3.75M | – | 133 |
|
|
2020
Q4 | $3.75M | Buy |
+24,774
| New | +$3.75M | 1.75% | 16 |
|
|
2018
Q4 | – | Sell |
-3,653
| Closed | -$445K | – | 97 |
|
|
2018
Q3 | $445K | Buy |
+3,653
| New | +$445K | 0.2% | 72 |
|
|
2018
Q1 | – | Sell |
-74,780
| Closed | -$7.98M | – | 105 |
|
|
2017
Q4 | $7.98M | Buy |
+74,780
| New | +$7.98M | 3.99% | 5 |
|
|
2015
Q3 | – | Sell |
-585
| Closed | -$216K | – | 99 |
|
|
2015
Q2 | $216K | Buy |
+585
| New | +$216K | 0.16% | 97 |
|